Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The designation "PDE4DIP pseudogene 7" refers to a hypothetical or computationally annotated pseudogene related to the *PDE4DIP* gene, which encodes myomegalin, a microtubule-associated anchoring protein involved in cAMP pathway regulation and microtubule organization. Pseudogenes are non-functional copies or remnants of genes and are not considered therapeutic targets. There is no evidence that "PDE4DIP pseudogene 7" encodes a functional protein, has a distinct biological or pharmacological role, or is listed in drug target or disease association databases. Any mention of "PDE4DIPP7" reflects either a misannotation or a speculative bioinformatics label, not a validated or actionable molecular target. *PDE4DIP* (myomegalin) is a real, protein-coding gene with well-documented roles in cell signaling and cytoskeletal organization. Mutations in *PDE4DIP* proper are associated with cardiac and neurological diseases, but there are no validated references for "PDE4DIP pseudogene 7" as a functional gene or clinical target. Pseudogenes, including those related to *PDE4DIP*, are often annotated automatically from genomic sequences and are typically nonfunctional due to disruptive mutations, frameshifts, or truncations. Some research explores *pseudogenes* as competitive endogenous RNAs (ceRNAs) that might indirectly regulate their parental gene's function, but there is no evidence that "PDE4DIP pseudogene 7" plays such a role. Only "PDE4DIPP2" has been discussed in recent ceRNA network studies. "PDE4DIP pseudogene 7" (PDE4DIPP7) is not a therapeutic target, does not encode a functional protein, and is likely a misnamed, misannotated, or non-informative pseudogene. There are no known drugs, functions, or disease roles associated with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDE4DIP pseudogene 7 (PDE4DIPP7).